Status:
COMPLETED
A Single Center Prospective Randomized Controlled Clinical Study of JANUS Stent in Patients With Coronary Artery Disease
Lead Sponsor:
Shenyang Northern Hospital
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Janus stent is the only marketed drug-eluting stent (DES) without polymer coating as yet in China. The goal of this study is to evaluate the efficacy of JANUS (Tacrolimus eluted stent) in inhibiting o...
Eligibility Criteria
Inclusion
- Patients who were eligible for coronary stenting
- All patients enrolled were implanted only one kind of stent
- Stent number ≤ 8 per patient and ≤3 per vessel (stents overlapping part for 3～5mm and being fully post-dilated; Total stent length ≤ 85mm in same vessel)
- Willing and able to sign informed consent.
Exclusion
- Patients with multi-vessel disease could not be implanted the same kind of stent
- In-stent restenosis target lesion
- Patients not eligible for DES implantation (e.g. intolerance to anti-platelet therapy or undergoing heart or non-heart surgery recently
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
September 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00406523
Start Date
February 1 2006
End Date
September 1 2007
Last Update
December 4 2006
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.